[go: up one dir, main page]

FI875086A7 - Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI875086A7
FI875086A7 FI875086A FI875086A FI875086A7 FI 875086 A7 FI875086 A7 FI 875086A7 FI 875086 A FI875086 A FI 875086A FI 875086 A FI875086 A FI 875086A FI 875086 A7 FI875086 A7 FI 875086A7
Authority
FI
Finland
Prior art keywords
farmaceutiska
benzotiadiazinfoereningar
blandningar
nya
foerfarande foer
Prior art date
Application number
FI875086A
Other languages
English (en)
Other versions
FI875086A0 (fi
Inventor
Teruo Oku
Eishiro Todo
Chiyoshi Kasahara
Katsuya Nakamura
Hiroshi Kayakiri
Masashi Hashimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868627857A external-priority patent/GB8627857D0/en
Priority claimed from GB878714598A external-priority patent/GB8714598D0/en
Priority claimed from GB878720659A external-priority patent/GB8720659D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI875086A0 publication Critical patent/FI875086A0/fi
Publication of FI875086A7 publication Critical patent/FI875086A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI875086A 1986-11-21 1987-11-18 Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI875086A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868627857A GB8627857D0 (en) 1986-11-21 1986-11-21 Benzothiadiazine compounds
GB878714598A GB8714598D0 (en) 1987-06-22 1987-06-22 Benzothiadiazine compounds
GB878720659A GB8720659D0 (en) 1987-09-02 1987-09-02 Benzothiadiazine compounds

Publications (2)

Publication Number Publication Date
FI875086A0 FI875086A0 (fi) 1987-11-18
FI875086A7 true FI875086A7 (fi) 1988-05-22

Family

ID=27263212

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875086A FI875086A7 (fi) 1986-11-21 1987-11-18 Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (9)

Country Link
US (1) US4889851A (fi)
EP (1) EP0268990A3 (fi)
JP (1) JP2564860B2 (fi)
KR (1) KR880006219A (fi)
CN (1) CN87107990A (fi)
AU (1) AU603842B2 (fi)
DK (1) DK597387A (fi)
FI (1) FI875086A7 (fi)
NO (1) NO874850L (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223237A (en) * 1987-01-22 1991-03-26 Shiseido Co Ltd Hair growth promoting agent and compositions
AU5883794A (en) * 1993-01-20 1994-08-15 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
FR2710062B1 (fr) * 1993-09-17 1995-12-01 Rhone Poulenc Rorer Sa Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
PL327617A1 (en) * 1995-10-23 1998-12-21 Zymogenetics Inc Compositions for and methods of treating osseous insufficiency
EP0973513A4 (en) * 1996-10-23 2003-03-19 Zymogenetics Inc COMPILATIONS AND METHOD FOR TREATING BONE DEFICIENCY
JP2002514192A (ja) * 1996-11-13 2002-05-14 セフアロン・インコーポレーテツド ベンゾチアゾおよび関連の複素環基を含有するシステインおよびセリンプロテアーゼ阻害剤
US5952328A (en) * 1997-11-12 1999-09-14 Cephalon, Inc. Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
BR0010700A (pt) 1999-04-30 2002-02-13 Slil Biomedical Corp Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata
WO2002047696A1 (de) * 2000-12-16 2002-06-20 Aventis Pharma Deutschland Gmbh Verwendung von niedermolekularen heparin zur behandlung von osteoarthrose
US20030130356A1 (en) * 2001-10-16 2003-07-10 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
KR100787130B1 (ko) * 2006-03-23 2007-12-21 한국화학연구원 신규의 치환된 1,1-다이옥소-벤조[1,2,4]티아디아진-3-온, 이의 제조방법 및 이를 포함하는 약학적 조성물
UA100120C2 (en) * 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1067028B (fi) * 1959-10-15
US3296070A (en) * 1967-01-03 Method for the treatment of hypertension
US3287362A (en) * 1966-11-22 Substituted j-oxo-j,x-dihydro-l,z,x-benzo- thiadiazine i,i-dioxides and a method for their preparation
US3267096A (en) * 1965-02-24 1966-08-16 Miles Lab Derivatives of 2h, 4h-benzothiadiazine 1, 1-dioxide
FR5571M (fi) * 1965-12-23 1967-11-27
US3892738A (en) * 1972-03-20 1975-07-01 Merck & Co Inc 7-Thiasubstituted-1,2,4-benzothiadiazine-1,1-dioxides and their salts
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives

Also Published As

Publication number Publication date
CN87107990A (zh) 1988-06-01
DK597387D0 (da) 1987-11-13
DK597387A (da) 1988-05-22
US4889851A (en) 1989-12-26
JP2564860B2 (ja) 1996-12-18
EP0268990A3 (en) 1988-08-10
NO874850L (no) 1988-05-24
JPS63183572A (ja) 1988-07-28
KR880006219A (ko) 1988-07-22
AU8146587A (en) 1988-05-26
EP0268990A2 (en) 1988-06-01
FI875086A0 (fi) 1987-11-18
NO874850D0 (no) 1987-11-20
AU603842B2 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
FI880546A7 (fi) Nya kolfibriller, foerfarande foer framstaellning daerav och kompositioner innehaollande desamma.
FI873142A7 (fi) Nya benzolsulfonamido -indanylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI886005A7 (fi) Nya, sulfhydrylgrupper innehaollande tricykliska laktamer och deras farmakologiska anvaendningsfoerfaranden.
FI892454L (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
FI875727L (fi) Nya oligosackarider, immunogener och vacciner och foerfarande foer framstaellning av saodana oligosackarider, immunogener och vacciner.
FI874323A7 (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI861153A0 (fi) Nya jodpropargyletrar, foerfarande foer deras framstaellning och deras anvaendning.
FI872841L (fi) Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna.
FI870274A0 (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI871052A7 (fi) Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI883347A7 (fi) Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner.
FI882385L (fi) Fosforhaltiga hmg-coa -reduktasinhibitorer, foerfarande foer framstaellning daerav och nya mellanprodukter.
FI875719A0 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI885811L (fi) Nya ammoniumfoereningar, deras framstaellning och anvaendning.
FI882477A7 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI875595A7 (fi) Nya bicykliska difosfonatfoereningar, farmaceutiska kompositioner och foerfarande foer behandling av avvikande kalcium- och fosfatmetabolism.
FI881816L (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873917A7 (fi) Nya naftalin- och indanderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI875086A7 (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873934A7 (fi) Nya naftylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI873243A7 (fi) Nya 1,4-benzodiazepiner, deras framstaellning och anvaendning.
FI873783A7 (fi) Nya sulfonamido-etylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI885056L (fi) Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI872635A7 (fi) Nya polypeptider, deras framstaellning och anvaendning.
FI883745A7 (fi) Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.